We describe the physiological function of heterologously expressed Mycobacterium tuberculosis InhA during de novo lipoic acid synthesis in yeast (Saccharomyces cerevisiae) mitochondria. InhA, representing 2-trans-enoyl-acyl carrier protein reductase and the target for the front-line antituberculous drug isoniazid, is involved in the activity of dissociative type 2 fatty acid synthase (FASII) that extends associative type 1 fatty acid synthase (FASI)-derived C20 fatty acids to form C60-to-C90 mycolic acids. Mycolic acids are major constituents of the protective layer around the pathogen that contribute to virulence and resistance to certain antimicrobials. Unlike FASI, FASII is thought to be incapable of de novo biosynthesis of fatty acids. Here, the genes for InhA (Rv1484) and four similar proteins (Rv0927c, Rv3485c, Rv3530c, and Rv3559c) were expressed in S. cerevisiae etr1 cells lacking mitochondrial 2-trans-enoyl-thioester reductase activity. The phenotype of the yeast mutants includes the inability to produce sufficient levels of lipoic acid, form mitochondrial cytochromes, respire, or grow on nonfermentable carbon sources. Yeast etr1 cells expressing mitochondrial InhA were able to respire, grow on glycerol, and produce lipoic acid. Commensurate with a role in mitochondrial de novo fatty acid biosynthesis, InhA could accept in vivo much shorter acyl-thioesters (C4 to C8) than was previously thought (>C12). Moreover, InhA functioned in the absence of AcpM or protein-protein interactions with its native FASII partners KasA, KasB, FabD, and FabH. None of the four proteins similar to InhA complemented the yeast mutant phenotype. We discuss the implications of our findings with reference to lipoic acid synthesis in M. tuberculosis and the potential use of yeast FASII mutants for investigating the physiological function of drug-targeted pathogen enzymes involved in fatty acid biosynthesis.
- American Society for Microbiology
- Function of heterologous mycobacterium tuberculosis inha, a type ...
Function of heterologous mycobacterium tuberculosis inha, a type 2 fatty acid synthase enzyme involved in extending c20 fatty acids to c60-to-c90 mycolic acids, during de novo lipoic acid synthesis in saccharomyces cerevisiae
Courtesy of American Society for Microbiology
What is a -150C Nitrogen freezer and who uses them?
A -150 C freezer, also known as a nitrogen freezer, is used in cryo preservation. While you might think of Ted Williams being frozen on ice for a future in which he can be brought back to life, the cryo preservation method can be used to keep any type of cell alive in a suspended state. Learn how nitrogen freezers are used and how PureAire can keep your facility safe. Who Uses Nitrogen Freezers? Nitrogen freezers use liquid nitrogen to freeze biological material in extremely cold temperatures. While they are...
Carbon Monoxide (CO) and Carbon Dioxide (CO2) Safety
Know the Gases, Know the Dangers and Protect Yourself Do you know the differences between carbon monoxide (CO) and carbon dioxide (CO2)? If you don’t then there are no guarantees your safety measures will be adequate. These two different gases are often mixed up with people becoming confused over which they need to protect against, when and how. To clear things up for those not in the know here’s a quick rundown without all the technical confusion. What do the gases have in common? While different...
Microbe Edition: Biological Nutrient Removal How In-Pipe Technology Works
Biological Nutrient Removal (BNR) is critical for tie preservation of our lakes and streams. Large amounts of waste products are passed through our sewage treatment systems on a continuous basis. Nutrient loads discharged from these systems must be reduced to avoid eutrophication of the receiving waters. Microbes are aarticularly useful in biodegrading most of the com sounds treated by wastewater treatment plants, in particular carbonaceous, nitrogenous, and phosphoric compounds. They do this in nature on a...
Copper oxide nanoparticles inhibit the metabolic activity of Saccharomyces cerevisiae
Copper oxide nanoparticles (CuO NPs) are increasingly used in industrial applications and consumer products and thus may pose risk to human and environmental health. The interaction of CuO NPs with complex media and the impact on cell metabolism when exposed to sublethal concentrations are largely unknown. In the present study, the short‐term effects of two different size manufactured CuO NPs on metabolic activity of Saccharomyces cerevisiae were studied. The role of released Cu2+ during dissolution of NPs in the...
Mold, Mold Growth and Buildings
Concern about mold exposures in buildings continues to be a significant issue. The bottom line is that mold has been around for eons and is not going away. It will grow whenever and wherever buildings get wet and materials suitable for mold growth are present. The following paragraphs are meant to shed light on mold issues related to microbiology, health and safety, moisture control, and remediation practices necessary to properly deal with areas of mold growth. What is Mold? Molds are members of the biologica...